AwesomeCapital
Search This Blog
Friday, December 6, 2019
Rocket Pharmaceuticals (RCKT) PT Raised to $41 at Baird, Added to Fresh Pick List
Baird analyst Madhu Kumar raised the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $41.00 (from $30.00).
https://www.streetinsider.com/Analyst+Comments/Rocket+Pharmaceuticals+%28RCKT%29+PT+Raised+to+%2441+at+Baird%2C+Added+to+Fresh+Pick+List/16217599.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.